Biosimilars

The Definitive Forum on the Legal, Regulatory, and Commercial Realities of Biosimilars

Tuesday, May 22 to Wednesday, May 23, 2012
New York Marriott East Side, New York, NY
Attend the one event where the industry leaders driving the business of biosimilars unite to set the standards which will shape an evolving legal and regulatory landscape

Hear what our prior delegates have to say about this event:

“One of the best CLEs I’ve been to in 10 years”
Maryann Wiskerchen, Counsel, Eli Lilly & Co. (prior delegate)

“Excellent program – informative and thought-provoking.”
Mark Bowditch, Patent Attorney, Sandoz Inc.

“I thought all the speakers did an excellent job in terms of content and delivery.”  Gregory York, Associate, Pearne & Gordon LLP

Attend the only event where the industry leaders driving the business of biosimilars come together to set the standards shaping the rapidly evolving legal and regulatory landscape

Whether you are on the branded or generic side, you cannot afford to miss this opportunity because you will:
  • Hear directly from the FDA on how they will implement the abbreviated pathway
  • Benchmark your strategy against market leaders such as Amgen, Dr. Reddy’s,
  • Eli Lilly, Merck, Momenta, Pfizer, Sandoz and many more
  • Gain priceless knowledge from the actual scientists, economists, in-house
  • and outside counsel thought leaders blazing the FDA’s biosimilar pathway
  • Network with peers facing the same regulatory, research and development cost, and patent management challenges in an true knowledge sharing environment

Gain the competitive advantage and fortify your patent portfolio in this swiftly burgeoning market as more companies announce their intentions to jump in the ring

With an estimated $150 billion in potential biologics revenue at stake annually and a wave of patent expirations starting in 2014, there will be a hard-fought battle to protect and increase market share. Ensure you’re prepared by registering for ACI’s Biosimilars Conference today by calling 888-224-2480, faxing your form to 877-927-1563, or registering online at www.AmericanConference.com/Biosimilars.